US Stock MarketDetailed Quotes

WST West Pharmaceutical Services

Watchlist
  • 214.730
  • +15.620+7.84%
Close Feb 14 16:00 ET
  • 213.190
  • -1.540-0.72%
Post 20:01 ET
15.55BMarket Cap32.10P/E (TTM)

West Pharmaceutical Services Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.73%180.1M
-2.48%165M
-14.41%118.2M
7.24%776.4M
3.55%239M
36.23%230.1M
-2.25%169.2M
-8.66%138.1M
Net income from continuing operations
----
----
-15.69%136M
-28.24%111.3M
-17.64%115.3M
1.28%593.4M
33.01%137M
33.75%161.3M
-17.72%155.1M
-19.45%140M
Operating gains losses
----
----
----
----
----
-125.87%-5.2M
45.28%-16.8M
--0
--2.2M
--9.4M
Depreciation and amortization
----
----
12.61%40.2M
14.08%38.9M
12.66%35.6M
13.85%137.3M
15.43%35.9M
19.80%35.7M
13.29%34.1M
6.76%31.6M
Deferred tax
----
----
----
----
----
221.75%37.5M
----
----
----
----
Other non cash items
----
----
-90.91%-2.1M
33.90%-3.9M
43.08%-3.7M
-92.48%1M
-53.53%14.5M
82.54%-1.1M
-43.90%-5.9M
13.33%-6.5M
Change In working capital
----
----
-100.40%-100K
155.73%14.1M
26.07%-34.6M
-36.00%-20.4M
-76.75%26.9M
177.02%24.8M
47.62%-25.3M
6.77%-46.8M
-Change in receivables
----
----
----
----
----
111.24%4M
----
----
----
----
-Change in inventory
----
----
----
----
----
72.89%-13.5M
----
----
----
----
-Change in payables and accrued expense
----
----
----
----
----
257.14%4.4M
----
----
----
----
-Change in other current assets
----
----
----
----
----
-215.14%-21.3M
----
----
----
----
-Change in other working capital
----
----
----
----
----
-89.03%6M
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-15.85%653.4M
-20.49%190.1M
-21.73%180.1M
-2.48%165M
-14.41%118.2M
7.25%776.5M
3.60%239.1M
36.23%230.1M
-2.25%169.2M
-8.66%138.1M
Investing cash flow
Cash flow from continuing investing activities
14.21%-82.1M
-23.26%-101.2M
-10.35%-90.6M
-27.93%-368.7M
-14.77%-108.8M
-61.93%-95.7M
-24.39%-82.1M
-20.20%-82.1M
Capital expenditure reported
204.14%377M
697.15%649.1M
15.14%-81.3M
-32.89%-100.2M
-10.35%-90.6M
-27.20%-362M
-14.54%-108.7M
-65.74%-95.8M
-14.07%-75.4M
-24.77%-82.1M
Net business purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net other investing changes
----
----
-900.00%-800K
----
----
-86.11%-6.7M
-200.00%-100K
107.69%100K
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
14.21%-82.1M
-23.26%-101.2M
-10.35%-90.6M
-27.93%-368.7M
-14.77%-108.8M
-61.93%-95.7M
-24.39%-82.1M
-20.20%-82.1M
Financing cash flow
Cash flow from continuing financing activities
-188.79%-64.4M
-23.47%-218.3M
-281.69%-271M
-56.54%-459.6M
-1,894.74%-189.5M
70.35%-22.3M
-388.40%-176.8M
58.89%-71M
Net issuance payments of debt
----
----
-483.33%-3.5M
-4,580.00%-23.4M
0.00%-600K
94.81%-2.3M
0.00%-600K
98.59%-600K
0.00%-500K
0.00%-600K
Net common stock issuance
----
----
-86.48%-52.4M
-7.34%-187.2M
-280.45%-272.4M
-103.06%-451.2M
-177,200.00%-177.1M
-2.18%-28.1M
-503.46%-174.4M
56.84%-71.6M
Cash dividends paid
----
----
-3.57%-14.5M
-3.55%-14.6M
-4.26%-14.7M
-5.36%-57M
-4.96%-14.8M
-3.70%-14M
-7.63%-14.1M
-5.22%-14.1M
Proceeds from stock option exercised by employees
----
----
-70.59%6M
-44.26%6.8M
9.80%16.8M
80.85%51M
-38.00%3.1M
142.86%20.4M
87.69%12.2M
84.34%15.3M
Net other financing activities
----
----
----
----
---100K
91.67%-100K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
----
----
-188.79%-64.4M
-23.47%-218.3M
-281.69%-271M
-56.54%-459.6M
-1,894.74%-189.5M
70.35%-22.3M
-388.40%-176.8M
58.89%-71M
Net cash flow
Beginning cash position
----
----
-43.97%446.2M
-32.10%601.8M
-4.52%853.9M
17.27%894.3M
23.26%898.6M
10.83%796.3M
32.74%886.3M
17.27%894.3M
Current changes in cash
----
----
-70.03%33.6M
-72.24%-154.5M
-1,522.67%-243.4M
-136.43%-51.8M
-146.80%-59.2M
223.99%112.1M
-226.52%-89.7M
83.30%-15M
Effect of exchange rate changes
----
----
213.27%11.1M
-266.67%-1.1M
-224.29%-8.7M
208.57%11.4M
-62.63%14.5M
59.34%-9.8M
98.51%-300K
237.25%7M
End cash Position
----
----
-45.37%490.9M
-43.97%446.2M
-32.10%601.8M
-4.52%853.9M
-4.52%853.9M
23.26%898.6M
10.83%796.3M
32.74%886.3M
Free cash flow
57.64%653.4M
254.45%462.2M
-26.43%98.8M
-30.92%64.8M
-50.71%27.6M
-5.67%414.5M
-4.05%130.4M
20.88%134.3M
-12.34%93.8M
-34.43%56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.73%180.1M-2.48%165M-14.41%118.2M7.24%776.4M3.55%239M36.23%230.1M-2.25%169.2M-8.66%138.1M
Net income from continuing operations ---------15.69%136M-28.24%111.3M-17.64%115.3M1.28%593.4M33.01%137M33.75%161.3M-17.72%155.1M-19.45%140M
Operating gains losses ---------------------125.87%-5.2M45.28%-16.8M--0--2.2M--9.4M
Depreciation and amortization --------12.61%40.2M14.08%38.9M12.66%35.6M13.85%137.3M15.43%35.9M19.80%35.7M13.29%34.1M6.76%31.6M
Deferred tax --------------------221.75%37.5M----------------
Other non cash items ---------90.91%-2.1M33.90%-3.9M43.08%-3.7M-92.48%1M-53.53%14.5M82.54%-1.1M-43.90%-5.9M13.33%-6.5M
Change In working capital ---------100.40%-100K155.73%14.1M26.07%-34.6M-36.00%-20.4M-76.75%26.9M177.02%24.8M47.62%-25.3M6.77%-46.8M
-Change in receivables --------------------111.24%4M----------------
-Change in inventory --------------------72.89%-13.5M----------------
-Change in payables and accrued expense --------------------257.14%4.4M----------------
-Change in other current assets ---------------------215.14%-21.3M----------------
-Change in other working capital ---------------------89.03%6M----------------
Cash from discontinued investing activities
Operating cash flow -15.85%653.4M-20.49%190.1M-21.73%180.1M-2.48%165M-14.41%118.2M7.25%776.5M3.60%239.1M36.23%230.1M-2.25%169.2M-8.66%138.1M
Investing cash flow
Cash flow from continuing investing activities 14.21%-82.1M-23.26%-101.2M-10.35%-90.6M-27.93%-368.7M-14.77%-108.8M-61.93%-95.7M-24.39%-82.1M-20.20%-82.1M
Capital expenditure reported 204.14%377M697.15%649.1M15.14%-81.3M-32.89%-100.2M-10.35%-90.6M-27.20%-362M-14.54%-108.7M-65.74%-95.8M-14.07%-75.4M-24.77%-82.1M
Net business purchase and sale ----------------------0----------------
Net other investing changes ---------900.00%-800K---------86.11%-6.7M-200.00%-100K107.69%100K--------
Cash from discontinued investing activities
Investing cash flow --------14.21%-82.1M-23.26%-101.2M-10.35%-90.6M-27.93%-368.7M-14.77%-108.8M-61.93%-95.7M-24.39%-82.1M-20.20%-82.1M
Financing cash flow
Cash flow from continuing financing activities -188.79%-64.4M-23.47%-218.3M-281.69%-271M-56.54%-459.6M-1,894.74%-189.5M70.35%-22.3M-388.40%-176.8M58.89%-71M
Net issuance payments of debt ---------483.33%-3.5M-4,580.00%-23.4M0.00%-600K94.81%-2.3M0.00%-600K98.59%-600K0.00%-500K0.00%-600K
Net common stock issuance ---------86.48%-52.4M-7.34%-187.2M-280.45%-272.4M-103.06%-451.2M-177,200.00%-177.1M-2.18%-28.1M-503.46%-174.4M56.84%-71.6M
Cash dividends paid ---------3.57%-14.5M-3.55%-14.6M-4.26%-14.7M-5.36%-57M-4.96%-14.8M-3.70%-14M-7.63%-14.1M-5.22%-14.1M
Proceeds from stock option exercised by employees ---------70.59%6M-44.26%6.8M9.80%16.8M80.85%51M-38.00%3.1M142.86%20.4M87.69%12.2M84.34%15.3M
Net other financing activities -------------------100K91.67%-100K----------------
Cash from discontinued financing activities
Financing cash flow ---------188.79%-64.4M-23.47%-218.3M-281.69%-271M-56.54%-459.6M-1,894.74%-189.5M70.35%-22.3M-388.40%-176.8M58.89%-71M
Net cash flow
Beginning cash position ---------43.97%446.2M-32.10%601.8M-4.52%853.9M17.27%894.3M23.26%898.6M10.83%796.3M32.74%886.3M17.27%894.3M
Current changes in cash ---------70.03%33.6M-72.24%-154.5M-1,522.67%-243.4M-136.43%-51.8M-146.80%-59.2M223.99%112.1M-226.52%-89.7M83.30%-15M
Effect of exchange rate changes --------213.27%11.1M-266.67%-1.1M-224.29%-8.7M208.57%11.4M-62.63%14.5M59.34%-9.8M98.51%-300K237.25%7M
End cash Position ---------45.37%490.9M-43.97%446.2M-32.10%601.8M-4.52%853.9M-4.52%853.9M23.26%898.6M10.83%796.3M32.74%886.3M
Free cash flow 57.64%653.4M254.45%462.2M-26.43%98.8M-30.92%64.8M-50.71%27.6M-5.67%414.5M-4.05%130.4M20.88%134.3M-12.34%93.8M-34.43%56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+4.45%
Strategy
MSTR
+3.94%
NVIDIA
NVDA
+2.63%
Vale SA
VALE
+1.99%
KB Home
KBH
+1.28%

Unlock the Full List